Reversal of the Hypomethylation Status of Urokinase (uPA) Promoter Blocks Breast Cancer Growth and Metastasis

Journal of Biological Chemistry - United States
doi 10.1074/jbc.m401669200
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)

Related search

The Role of uPA and uPA Inhibitors in Breast Cancer

Breast Care
SurgeryOncology
2008English

CCR5 Antagonist Blocks Metastasis of Basal Breast Cancer Cells

Cancer Research
Cancer ResearchOncology
2012English

Small Interfering RNA Directed Reversal of Urokinase Plasminogen Activator Demethylation Inhibits Prostate Tumor Growth and Metastasis

Cancer Research
Cancer ResearchOncology
2007English

GATA3 Inhibits Breast Cancer Metastasis Through the Reversal of Epithelial-Mesenchymal Transition

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2010English

Significant Association of EED Promoter Hypomethylation With Colorectal Cancer

Oncology Letters
Cancer ResearchOncology
2019English

Downregulation of miR-193b Contributes to Enhance Urokinase-Type Plasminogen Activator (uPA) Expression and Tumor Progression and Invasion in Human Breast Cancer

Oncogene
Cancer ResearchGeneticsMolecular Biology
2009English

Synthetic Cannabinoid Receptor Agonists Inhibit Tumor Growth and Metastasis of Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2009English

Urokinase-Type Plasminogen Activator (PLAU; uPA); Thrombin (F2)

Science-Business eXchange
2010English

Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy